Tag archive


Editorial: FDA Approval of a New Cannabis-based Drug ‘Epidiolex’ Shocks the Pharmaceutical Market

in Editors' Picks/Pharmaceutical Articles
Epidiolex by GW Pharma

Epidiolex, the catchy name of a new drug to treat complex seizures, has generated a wave of controversy around the medical world. Federal advisers recommended the approval of the first prescription drug in which the main component is cannabidiol (CBD), a natural cannabis’ derivative with low addictive power. This drug would be approved just for the treatment of seizures caused by the Lennox-Gastaut and Dravet syndromes, Complex Tuberous Sclerosis and Infant Spasms. Epidiolex represents a new hope for people living…

Keep Reading

Battery Performance and Cybersecurity Firmware Updates for Abbott Implantable Cardiac Devices

in Pharmaceutical News
Battery Performance Alert and Cybersecurity Firmware Updates for Certain Abbott Implantable Cardiac Devices

The FDA approved a firmware update that is now available and is intended as a corrective action (recall), to reduce the risk of patient harm due to premature battery depletion and potential exploitation of cybersecurity vulnerabilities for certain Abbott ICDs and CRT-Ds. “Firmware” is a specific type of software embedded in the hardware of a medical device (e.g. a component in the defibrillator). The FDA recommends that all eligible patients receive the firmware update at their next regularly scheduled visit…

Keep Reading

1 2 3 9
Go to Top